Benign prostatic hyperplasia (BPH) is a condition that affects a significant number of men.<\/p>\n\n\n\n
The symptoms can be uncomfortable, making it difficult to urinate normally, as well as causing sexual dysfunction. <\/p>\n\n\n\n
The risk for benign prostatic hyperplasia significantly increases with age. <\/p>\n\n\n\n
By the age of 40, only 8% of men will experience signs that are associated with this condition1. <\/p>\n\n\n\n
Benign prostatic hyperplasia affects the prostate gland. As the condition develops, the prostate gland of the patient becomes enlarged. <\/p>\n\n\n\n
This can affect the functioning of the urinary tract and bladder. The result may be urinary tract symptoms, including urinary retention<\/a>, and erectile dysfunction. <\/p>\n\n\n\n 5-Alpha Reductase Inhibitors is a term used to describe a family of pharmaceutical drugs, often prescribed to men diagnosed with benign prostatic hyperplasia. <\/p>\n\n\n\n These drugs target specific chemicals in the patient’s body to potentially reduce the size of the prostate. It should, however, be noted that not all of these drugs will effectively help to treat the enlarged prostate<\/a>. <\/p>\n\n\n\n Some of these drugs, instead only work to assist in reducing the severity of the symptoms. <\/p>\n\n\n\n Different types of 5-Alpha Reductase Inhibitors have been developed in the last few years2. <\/p>\n\n\n\n Male patients are advised to gain more insight and select the drug type that would yield the best results for their specific condition. <\/p>\n\n\n\n <\/p>\n\n\n\n What are 5-Alpha Reductase Inhibitors? <\/h2>\n\n\n\n
Get Your FREE PSA Lowering Diet Plan! <\/h3>\n
\n